Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.52 |
| ▸ | CA2 | P00918 | 2/20 | 0.52 |
| ▸ | CA3 | P07451 | 2/20 | 0.52 |
| ▸ | CA9 | Q16790 | 2/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | GLA | P06280 | 1/20 | 0.52 |
| ▸ | CA4 | P22748 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | MMP3 | P08254 | 2/20 | 0.39 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 6/20 | 0.38 |
| ▸ | ESR1 | P03372 | 5/20 | 0.38 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | CA6 | P23280 | 1/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.36 |
| ▸ | LTA4H | P09960 | 1/20 | 0.34 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.34 |
| ▸ | BAX | Q07812 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenol SCHEMBL1525247 | 0.90 | CA12 (0.65) | CA12CA2CA3CA9CA14 | |
| Phenol SCHEMBL27571305 | 0.90 | CA12 (0.42) | CA12CA2CA3CA9CA14 | |
| Phenol SCHEMBL177595 | 0.90 | CA12 (0.42) | CA12CA2CA3CA9CA14 | |
| Phenol SCHEMBL7096499 | 0.88 | CA12 (0.55) | CA12CA2CA3CA9CA14 | |
| Phenol SCHEMBL28215094 | 0.84 | CA12 (0.73) | CA12CA2CA3CA9CA14 | |
| Phenol SCHEMBL27329051 | 0.84 | CA12 (0.73) | CA12CA2CA3CA9CA14 | |
| Phenol SCHEMBL42361 | 0.84 | CA12 (0.73) | CA12CA2CA3CA9CA14 | |
| Phenol SCHEMBL28084399 | 0.84 | CA12 (0.73) | CA12CA2CA3CA9CA14 | |
| Phenol SCHEMBL8718742 | 0.84 | CA12 (0.73) | CA12CA2CA3CA9CA14 | |
| Phenol SCHEMBL28042326 | 0.82 | CA12 (0.69) | CA12CA2CA3CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 465 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240209345-A1 | COMPOSITIONS AND METHODS FOR HIGH STRINGENCY ISOLATION OF NUCLEIC ACIDS | DUKE UNIVERSITY | 2024-06-27 | — | — | US | claimed |
| CN-1276428-A | Clone and expression of anti-CA125 bifunctional genetically engineered antibody | MAILING BIO ENGINEERING CO LTD (CN) | 2000-12-13 | — | — | CN | claimed |
| EP-3532637-B1 | METHOD FOR ISOLATION OF EUKARYOTIC NUCLEIC ACIDS FROM STOOL SAMPLES | GENEOSCOPY INC (US) | 2024-07-10 | — | — | EP | disclosed |
| US-20240209345-A1 | COMPOSITIONS AND METHODS FOR HIGH STRINGENCY ISOLATION OF NUCLEIC ACIDS | DUKE UNIVERSITY | 2024-06-27 | — | — | US | disclosed |
| US-20240197783-A1 | METHODS OF TREATMENT AND DOSING OF NATURAL KILLER CELL COMPOSITIONS | INDAPTA THERAPEUTICS, INC. (US) | 2024-06-20 | — | — | US | disclosed |
| EP-4362957-A1 | ENGINEERED NATURAL KILLER (NK) CELLS AND RELATED METHODS | Indapta Therapeutics, Inc. (US) | 2024-05-08 | — | — | EP | disclosed |
| US-20240093312-A1 | DETECTION METHOD | GENEOSCOPY INC (US) | 2024-03-21 | — | — | US | disclosed |
| EP-4326288-A1 | METHODS OF TREATMENT AND DOSING OF NATURAL KILLER CELL COMPOSITIONS | Indapta Therapeutics, Inc. (US) | 2024-02-28 | — | — | EP | disclosed |
| US-20240060116-A1 | Detection of Co-Occurring Receptor-Coding Nucleic Acid Segments | AKOYA BIOSCIENCES, INC. | 2024-02-22 | — | — | US | disclosed |
| CN-110291197-B | Detection method | 基因复制股份有限公司 | 2024-01-12 | — | — | CN | disclosed |
| WO-2024007020-A1 | COMBINATION OF ENGINEERED NATURAL KILLER (NK) CELLS AND ANTIBODY THERAPY AND RELATED METHODS | INDAPTA THERAPEUTICS, INC. (US) | 2024-01-04 | — | — | WO | disclosed |
| US-5631128-A | VIRICIDES USING REVERSE TRANSCRIPASE FOR TREATMENT OF AIDS AS ANTIRETROVIRAL DRUGS | LELAND STANFORD JUNIOR UNIVERSITY (US) | 1997-05-20 | — | — | US | disclosed |
| EP-0621895-A4 | INHIBITION OF THE FORMATION OR ACTIVITY OF HUMAN LEUKOCYTE 12-LIPOXYGENASE PATHWAY. | HOPE CITY (US) | 1996-11-27 | — | — | EP | disclosed |
| WO-1995033831-A1 | METHODS AND COMPOSITIONS FOR MODULATING MORPHOGENIC PROTEIN EXPRESSION | CREATIVE BIOMOLECULES, INC. (US) | 1995-12-14 | — | — | WO | disclosed |
| WO-1995027783-A1 | INHIBITION OF HIV-1 MULTIPLICATION IN MAMMALIAN CELLS | JOSHI SUKHWAL SADNA (CA) | 1995-10-19 | — | — | WO | disclosed |
| WO-1994025063-A1 | VACCINATION AND METHODS AGAINST MULTIPLE SCLEROSIS RESULTING FROM PATHOGENIC RESPONSES BY SPECIFIC T CELL POPULATIONS | THE IMMUNE RESPONSE CORPORATION (US) | 1994-11-10 | — | — | WO | disclosed |
| EP-0621895-A1 | INHIBITION OF THE FORMATION OR ACTIVITY OF HUMAN LEUKOCYTE 12-LIPOXYGENASE PATHWAY | CITY OF HOPE (US) | 1994-11-02 | — | — | EP | disclosed |
| EP-0610436-A1 | HEPATITIS-C VIRUS TESTING | COMMON SERVICES AGENCY (GB) | 1994-08-17 | — | — | EP | disclosed |
| WO-1994005777-A1 | INHIBITION OF THE FORMATION OR ACTIVITY OF HUMAN LEUKOCYTE 12-LIPOXYGENASE PATHWAY | CITY OF HOPE (US) | 1994-03-17 | — | — | WO | disclosed |
| WO-1993010239-A2 | HEPATITIS-C VIRUS TESTING | COMMON SERVICES AGENCY (GB) | 1993-05-27 | — | — | WO | disclosed |